EF
LMAT icon

Empowered Funds’s LeMaitre Vascular LMAT Stock Holding History

Empowered Funds’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$397K Buy
4,134
+990
+31% +$102K ﹤0.01% 1765
2026
Q1 		$343K Buy
+3,144
New +$300K ﹤0.01% 1771
2025
Q1 		– Sell
-1,626
Closed -$150K – 1725
2024
Q4 		$150K Buy
+1,626
New +$156K ﹤0.01% 1546

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Empowered Funds's LMAT Position: Q2 2026 in Review

Empowered Funds increased its LeMaitre Vascular (LMAT) stake by 31% in Q2 2026, buying an estimated $102K and bringing the position to 4,134 shares worth $397K. The position accounts for ﹤0.01% of the portfolio, ranked #1765.

Empowered Funds first reported a position in LMAT in Q4 2024 and has held it in 3 quarters since. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Empowered Funds held 4,134 shares of LeMaitre Vascular worth $397K as of Q2 2026.
  • Empowered Funds bought 990 LeMaitre Vascular shares in Q2 2026, an estimated $102K.
  • LeMaitre Vascular made up ﹤0.01% of Empowered Funds's portfolio in Q2 2026, its #1765 holding.
  • Empowered Funds first reported a position in LeMaitre Vascular in Q4 2024 and has held it in 3 quarters since.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.